Home2B4 • FRA
Bonesupport Holding AB
€29.64
Jan 30, 11:00:08 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed security
Previous close
€29.50
Day range
€29.64 - €29.64
Year range
€15.20 - €39.42
Market cap
22.31B SEK
Avg Volume
147.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK)Sep 2024Y/Y change
Revenue
237.50M50.12%
Operating expense
173.42M33.15%
Net income
30.57M-86.64%
Net profit margin
12.87-91.10%
Earnings per share
EBITDA
47.67M200.68%
Effective tax rate
24.73%
Total assets
Total liabilities
(SEK)Sep 2024Y/Y change
Cash and short-term investments
153.16M-6.64%
Total assets
778.65M23.41%
Total liabilities
116.85M15.34%
Total equity
661.80M
Shares outstanding
65.81M
Price to book
2.93
Return on assets
15.41%
Return on capital
17.86%
Net change in cash
(SEK)Sep 2024Y/Y change
Net income
30.57M-86.64%
Cash from operations
42.35M158.74%
Cash from investing
-833.00K-45.63%
Cash from financing
-1.21M39.61%
Net change in cash
38.58M169.89%
Free cash flow
32.07M147.62%
About
BoneSupport AB is a Swedish biotech company active at the Ideon Science Park in the university town of Lund in Skåne, Sweden, founded in 1999 by Lars Lidgren, Professor of Orthopedic Surgery and Academic Head of Department at Lund University Hospital in Sweden which is a member of the ISOC group of orthopaedic centers. The company has been funded with more than SEK 500 million in venture capital from inter alia HealthCap, Lundbeck foundation and Industrifonden, making it one of the largest ventures in the Swedish medical technologies industry. Wikipedia
Founded
1999
Employees
131
Search
Clear search
Close search
Google apps
Main menu